Olema Pharmaceuticals, Inc. OLMA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s retained earnings?
- Olema Pharmaceuticals, Inc. (OLMA) reported retained earnings of -$650.65M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s retained earnings changed year-over-year?
- Olema Pharmaceuticals, Inc.'s retained earnings decreased by 39.8% year-over-year, from -$465.5M to -$650.65M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s retained earnings has grown at a 78.4% compound annual growth rate (CAGR), from -$33.09M to -$597.56M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.